Likarda
Stephen Harrington has a diverse background in research and development, with experience in biomaterials, manufacturing oversight, and product development. Stephen has worked in various positions at Likarda, LLC, focusing on hydrogel formulation, cell encapsulation, and islet transplantation for diabetes treatment. Harrington also has experience as a research assistant at the University of Kansas Medical Center and as a Lab Technician III at Pace Analytical. Stephen holds a Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering from the University of Kansas, following a Bachelor of Science (BS) in Chemistry from Emporia State University.
This person is not in any offices
Likarda
1 followers
Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Their revolutionary method to coat cells with stealth hydrogels, called Core-Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body.